CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
|
2 Months Ended |
12 Months Ended |
Dec. 31, 2019 |
Dec. 31, 2020 |
| Cash Flows from Operating Activities: |
|
|
| Net loss |
$ (17,631)
|
$ (6,744,840)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Interest earned on cash and marketable securities held in Trust Account |
|
(117,255)
|
| Changes in operating assets and liabilities: |
|
|
| Prepaid expenses |
|
(299,666)
|
| Accrued expenses |
|
4,934,643
|
| Net cash used in operating activities |
(17,631)
|
(2,227,118)
|
| Cash Flows from Investing Activities: |
|
|
| Investment of cash in Trust Account |
|
(828,000,000)
|
| Net cash used in investing activities |
|
(828,000,000)
|
| Cash Flows from Financing Activities: |
|
|
| Proceeds from issuance of Class B ordinary shares to Sponsor |
|
25,000
|
| Proceeds from sale of Units, net of underwriting discounts paid |
|
813,600,000
|
| Proceeds from sale of Private Placement Warrants |
|
16,400,000
|
| Advances from related party |
17,631
|
193,137
|
| Repayment of advances from related parties |
|
(17,631)
|
| Proceeds from Investors in connection with business combination |
|
95,999,990
|
| Repayment of Investors funds in connection with business combination |
|
(68,000,000)
|
| Proceeds from promissory note—related party |
|
1,106,208
|
| Repayment of promissory note—related party |
|
(300,000)
|
| Payment of offering costs |
|
(776,346)
|
| Net cash provided by financing activities |
17,631
|
858,230,358
|
| Net Change in Cash |
|
28,003,240
|
| Cash—Beginning |
|
0
|
| Cash—Ending |
0
|
28,003,240
|
| Non-cash investing and financing activities: |
|
|
| Initial classification of ordinary shares subject to possible redemption |
|
795,251,020
|
| Change in value of ordinary shares subject to possible redemption |
|
(6,744,844)
|
| Deferred underwriting fee |
|
28,980,000
|
| Deferred offering cost included in accrued offering costs |
$ 100,346
|
$ 0
|